Get Best Atezolizumab Tecentriq 1200 mg Injection price in india at Yourmedikart. Tecentriq, known for its active component Atezolizumab, is a significant advancement in immunotherapy treatments. It is available in various global markets.

Tecentriq 1200 mg, known as Atezolizumab, is used to treat specific types of cancer, including non-small cell lung cancer, urothelial cancer (a type of cancer of the bladder and urinary tract), and breast cancer. This medication is administered via injection by a healthcare professional.

Your doctor will tailor the dosing schedule based on your condition and response to treatment. Incorrect administration can lead to serious side effects. Notify your medical advisor if you are using other medications. Tecentriq Atezolizumab 1200 mg Injection price in india best at Yourmedikart

Tecentriq 1200mg/20ml

ROCHE

GENERIC NAME : ATEZOLIZUMAB

PACKING: 1200mg/20ml

Tecentriq Atezolizumab price in india

  • Tecentriq 1200 mg known as atezolizumab price 1200 mg. Atezolizumab is used to treat certain types of cancer, such as non-small cell lung cancer, Tecentriq 1200 mg urothelial cancer (a type of cancer of the bladder and urinary tract), and breast cancer.
  • Therefore Tecentriq Roche medicine is given as an injection by a doctor or nurse.
  • Your doctor will decide on the Tecentriq pi dosing schedule depending on your condition and response to treatment. Do not take this medication the wrong way as However it can lead to serious side effects. Inform your medical advisor if you are using other medications.
  • Tecentriq 1200 mg price in india also known as Atezolizumab price in india. Atezolizumab Tecentriq 1200 mg injection price in india is similar Atezolizumab price cost of Tecentriq low in india at yourmedikart.

What is Tecentriq ?

Tecentriq may used when your bladder cancer:

  • Has spread or cannot removed by surgery (advanced urothelial carcinoma)
  • You are not able to take chemotherapy that contains a medicine called cisplatin,
  •  Most Importantly have tried chemotherapy that contains platinum, and it did not work or is no longer working.

Therefore, Tecentriq is a medicine designed to treat your bladder cancer and is thought to work with your body’s own immune system to fight cancer cells. Also, tecentriq atezolizumab 1200 mg injection It may also affect normal cells.

How Does Tecentriq Work?

  • Firstly Your immune system is a collection of specialized organs and cells that help protect you against infection and disease.3However, a protein called PD-L1 found on many cells, including cancer cells, can allow cancer cells to hide from your immune system. When PD-L1 on cancer cells binds to specific proteins on your immune cells, tecentriq atezolizumab 1200 mg injection it may prevent your immune system from able to recognize and kill your cancer.2
  • Tecentriq is an anti-PDL1 antibody, meaning it is designed to block PD-L1. By blocking PD-L1. Tecentriq is thought to boost your body’s own immune system to target and kill cancer cells that hide using PD-L1. TECENTRIQ may also affect normal cells.

tecentriq atezolizumab

Tecentriq (Atezolizumab) has emerge as a groundbreaking immunotherapy for various cancers, offering new hope for patients seeking effective treatments. Known for its potent ability to empower the immune system against cancer cells.

Tecentriq has made widely available in several global markets, Tecentriq atezolizumab 1200 mg injection including India. Its accessibility is a result of both its efficacy in clinical settings and strategic pricing, making it a viable option for a wide range of patients, from those in highly developed healthcare systems to those in emerging markets.

Understanding Tecentriq (Atezolizumab) and Its Mechanism

  • Tecentriq is an innovative immunotherapy drug, specifically classified as an anti-PDL1 antibody. This drug works by targeting the Programmed Death-Ligand 1 (PD-L1), a protein found on the surface of many cancer cells.
  • PD-L1 enables cancer cells to evade the immune system by binding to the PD-1 receptor on T cells, which are a type of immune cell. By inhibiting PD-L1, Tecentriq helps expose the cancer cells to the immune system, enabling a more effective immune response against the tumor cells.
  • This mechanism of action has proven effective in treating several types of cancer, including non-small cell lung cancer (NSCLC), urothelial carcinoma (a type of bladder cancer), and triple-negative breast cancer, among others. Tecentriq ability to modulate the immune response makes it a critical component of cancer treatment regimens, particularly for patients who have not respond to conventional chemotherapy or for those whose cancer has advanced to a more severe stage.

tecentriq

Pricing and Availability in India

  • In India, Tecentriq is available through Yourmedikart, an online platform that facilitates the distribution of various medications at competitive prices. The cost of Tecentriq in India reflects a strategic approach to make this advance treatment accessible to a broader range of patients.
  • Given the complexity and expense associate with immunotherapy treatments, the availability of Tecentriq atezolizumab tecentriq injection at a reduce price in India represents a significant advancement in making cutting-edge medical treatments more widely accessible.
  • The pricing strategy for Tecentriq in India is reflective of a broader trend in pharmaceutical marketing. Where drug prices are often adjust base on the economic conditions and healthcare capabilities of different regions.
  • This tiered pricing strategy helps to balance the need for pharmaceutical companies to recoup research. And however, development costs with the imperative to provide access to life-saving treatments across diverse socioeconomic landscapes.

Dosage and Administration

Tecentriq is administer intravenously, typically over a 60-minute session, once every three weeks. This dosing schedule may continue depending on the patient’s response and tolerance to the treatment. It is critical that the administration of Tecentriq is conduct under the supervision of a qualify healthcare professional to manage any potential adverse effects and to ensure the treatment’s efficacy.

The dosage, typically Tecentriq 1200 mg/20ml, is determine. By the treating physician base on the type and severity of the cancer. As well as the patient’s overall health and treatment history. It’s crucial for patients to follow the dosing schedule precisely and attend all treatment sessions to achieve the best possible outcome.

Side Effects

While Tecentriq has offer significant benefits in treating various cancers, like all medications, it can cause side effects. Common side effects include fatigue, nausea, loss of appetite, and potential immune-relate adverse effects such as pneumonitis. Hepatitis, colitis, hormonal gland problems, and skin reactions. More severe complications might include infusion-relate reactions. Which can manifest as fever, chills, shortness of breath, and chest pain during or after the administration of the drug.

Patients must be monitor for signs of immune system overactivity. As Tecentriq can cause the immune system to attack normal organs and tissues. Potentially leading to serious or life-threatening conditions. Therefore, it is paramount that patients receiving Tecentriq are closely supervise by healthcare professionals who can swiftly address any adverse effects.

Precautions

Before starting treatment with Atezolizumab, inform your healthcare provider about all your medical conditions, including any immune system issues. Previous organ transplants, or existing health conditions that might affect treatment. Pregnancy must be avoid during treatment and for five months thereafter due to potential harm to the unborn baby. Additionally, breastfeeding is not recommend during treatment and for five months following the last dose.

Economic and Clinical Impact in India

The introduction of Tecentriq in the Indian market has had both economic and clinical implications. Economically, it provides a cost-effective alternative for immunotherapy, which can often be prohibitively expensive. Clinically, it offers a promising treatment option for patients who may have limit choices. Especially in cases where cancer has proven resistant to other forms of treatment.

Moreover, the availability of Tecentriq in India enhances the country’s portfolio of advance medical treatments and supports. Its growing reputation as a hub for innovative healthcare solutions. Similarly This is particularly significant in a country where the burden of cancer is rising steadily and the need for effective. Because Affordable treatment options is becoming increasingly urgent.

Self-Care Tips

Maintain adequate hydration, manage nausea effectively, Moreover, avoid sun exposure, and limit alcohol consumption. Ensure proper rest and nutrition, and practice good hygiene to reduce infection risks. Discuss any new symptoms or side effects with your healthcare team to manage them effectively.

Conclusion

Tecentriq represents a major advancement in the field of oncology. Bringing hope and new possibilities to patients battling tough cancer diagnoses. So, its availability and strategic pricing in India illustrate a significant step forward in democratizing access to advance medical treatments. Tecentriq Atezolizumab 1200 mg Injection price in india best at Yourmedikart

FAQ

What is TECENTRIQ used for?

TECENTRIQ is a prescription drug used to treat adults with the following diseases: In other words a type of bladder and urinary tract cancer called urothelial cancer.

Is TECENTRIQ a chemo drug?

Use Tecentriq alone. A chemotherapy drug called gemcitabine, After that used in combination with placebo and platinum-based chemotherapy (carboplatin or cisplatin)

What type of drug is TECENTRIQ?

Tecentriq (atezolizumab) is a monoclonal antibody that can affect the activity of the human immune system. For instance, Atezolizumab strengthens your immune system and helps your body fight tumor cells. Tecentriq is used to treat adults with the following conditions: A type of bladder and urinary tract cancer called urothelial cancer.

How long can you stay on TECENTRIQ?

Your healthcare provider will give you TECENTRIQ into your vein through an intravenous (IV) line over 30 to 60 minutes. TECENTRIQ is usually given every 2, 3, or 4 weeks. Your healthcare provider will decide how many treatments you need.

Is TECENTRIQ an immunotherapy?

TECENTRIQ is a malignant growth immunotherapy that can assist with reactivating the immune system so it can recognize cancer cells in the body.

WhatsApp us